A detailed history of Rhumbline Advisers transactions in Conmed Corp stock. As of the latest transaction made, Rhumbline Advisers holds 90,838 shares of CNMD stock, worth $6.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
90,838
Previous 93,240 2.58%
Holding current value
$6.8 Million
Previous $6.46 Million 1.08%
% of portfolio
0.01%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$64.09 - $76.92 $153,944 - $184,761
-2,402 Reduced 2.58%
90,838 $6.53 Million
Q2 2024

Aug 01, 2024

BUY
$61.9 - $80.36 $36,521 - $47,412
590 Added 0.64%
93,240 $6.46 Million
Q1 2024

May 09, 2024

SELL
$75.36 - $112.51 $175,287 - $261,698
-2,326 Reduced 2.45%
92,650 $7.42 Million
Q4 2023

Feb 08, 2024

SELL
$91.3 - $115.05 $363,282 - $457,783
-3,979 Reduced 4.02%
94,976 $10.4 Million
Q3 2023

Nov 09, 2023

BUY
$97.55 - $135.91 $77,357 - $107,776
793 Added 0.81%
98,955 $9.98 Million
Q2 2023

Aug 08, 2023

BUY
$102.55 - $136.38 $128,905 - $171,429
1,257 Added 1.3%
98,162 $13.3 Million
Q1 2023

May 11, 2023

BUY
$89.75 - $107.27 $334,947 - $400,331
3,732 Added 4.01%
96,905 $10.1 Million
Q4 2022

Feb 14, 2023

BUY
$72.84 - $94.04 $212,110 - $273,844
2,912 Added 3.23%
93,173 $8.26 Million
Q3 2022

Nov 10, 2022

BUY
$77.78 - $103.92 $419,389 - $560,336
5,392 Added 6.35%
90,261 $7.24 Million
Q2 2022

Aug 11, 2022

BUY
$88.23 - $154.18 $294,247 - $514,190
3,335 Added 4.09%
84,869 $8.13 Million
Q1 2022

May 12, 2022

BUY
$121.88 - $150.0 $584,780 - $719,700
4,798 Added 6.25%
81,534 $12.1 Million
Q4 2021

Feb 10, 2022

SELL
$129.86 - $157.03 $87,136 - $105,367
-671 Reduced 0.87%
76,736 $10.9 Million
Q3 2021

Nov 12, 2021

SELL
$122.87 - $139.12 $1.4 Million - $1.58 Million
-11,378 Reduced 12.82%
77,407 $10.1 Million
Q2 2021

Aug 05, 2021

BUY
$128.08 - $145.09 $63,271 - $71,674
494 Added 0.56%
88,785 $12.2 Million
Q1 2021

May 06, 2021

BUY
$111.35 - $130.59 $150,990 - $177,080
1,356 Added 1.56%
88,291 $11.5 Million
Q4 2020

Feb 10, 2021

BUY
$77.7 - $112.82 $273,659 - $397,352
3,522 Added 4.22%
86,935 $9.74 Million
Q3 2020

Nov 12, 2020

SELL
$69.87 - $89.2 $720,289 - $919,562
-10,309 Reduced 11.0%
83,413 $6.56 Million
Q2 2020

Aug 13, 2020

SELL
$50.31 - $81.76 $210,346 - $341,838
-4,181 Reduced 4.27%
93,722 $6.75 Million
Q1 2020

May 06, 2020

BUY
$39.81 - $112.01 $25,836 - $72,694
649 Added 0.67%
97,903 $5.61 Million
Q4 2019

Feb 05, 2020

BUY
$93.31 - $116.55 $566,578 - $707,691
6,072 Added 6.66%
97,254 $10.9 Million
Q3 2019

Oct 23, 2019

BUY
$83.97 - $102.19 $470,064 - $572,059
5,598 Added 6.54%
91,182 $8.77 Million
Q2 2019

Aug 14, 2019

BUY
$78.27 - $86.94 $144,095 - $160,056
1,841 Added 2.2%
85,584 $7.32 Million
Q1 2019

May 01, 2019

BUY
$60.79 - $83.18 $64,255 - $87,921
1,057 Added 1.28%
83,743 $6.97 Million
Q4 2018

Jan 31, 2019

BUY
$57.41 - $79.06 $757,697 - $1.04 Million
13,198 Added 18.99%
82,686 $5.31 Million
Q2 2018

Aug 06, 2018

SELL
$61.34 - $76.43 $149,240 - $185,954
-2,433 Reduced 3.38%
69,488 $5.09 Million
Q1 2018

May 02, 2018

BUY
$50.61 - $64.53 $3,188 - $4,065
63 Added 0.09%
71,921 $4.56 Million
Q4 2017

Feb 09, 2018

BUY
$49.3 - $54.24 $305,314 - $335,908
6,193 Added 9.43%
71,858 $3.66 Million
Q3 2017

Nov 06, 2017

BUY
$48.38 - $52.52 $3.18 Million - $3.45 Million
65,665
65,665 $3.45 Million

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.28B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.